Why the study?
Should warfarin be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation?
Should warfarin be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation?
This article discusses caveats regarding the use of warfarin as the primary choice for thromboprophylaxis in elderly patients with atrial fibrillation.
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation' - Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation -
No takes yet. Share an insight, caveat, or question.
Elaine M. Hylek (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: